• Go to navigation
  • Go to content
SEROQUEL (quetiapine)

Astrazeneca Worldwide

  • AstraZeneca Websites
az.com
  • Home

Main navigation

  • Home
  • SEROQUEL and SEROQUEL XR Prescribing information
  • SEROQUEL Mode of Action
  • SEROQUEL XR in schizophrenia
  • SEROQUEL in Schizophrenia
  • SEROQUEL in bipolar mania
  • Key publications
  • Assessment tools
  • SEROQUEL Information for patients
  • SEROQUEL XR Information for patients
  • Resources
  • About AstraZeneca
  • Sitemap
SEROQUEL (quetiapine)

Welcome to the SEROQUEL Information website.

The site is intended for an international audience of healthcare professionals

  • International HCPs

    please continue to SEROQUEL Information Website
  • International audience of patient and carers

    please go to Patient Health International
  • Seroquel Information links

      SEROQUEL Country sites

    • SEROQUEL Germany
    • SEROQUEL Holland
    • SEROQUEL China
  • Audience specific sites

    • US healthcare professionals, please go to SEROQUEL US
    • US patients, please go to SEROQUEL US for patients 
    • UK residents, please go to AstraZeneca UK
AstraZeneca Pharmaceuticals is committed to high standards of information provision. This site has been prepared for a global audience with reference to the IFPMA code of marketing practices and the Health on the Net code, as well as our high company standards.

Should you have any questions or concerns about this site please contact: infomaster@astrazeneca.com

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2010